Autoimmune hepatitis associated Hepatitis C virus infection treated with fi rst generation direct-acting antivirals | Zendy

JD Castro Limo | Zendy; TA Varasa | Zendy; MR Pradillo | Zendy; MR Gutierrez | Zendy; Gomez Moreno AZ | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Autoimmune hepatitis associated Hepatitis C virus infection treated with fi rst generation direct-acting antivirals

Author(s) -

JD Castro Limo,

TA Varasa,

MR Pradillo,

MR Gutierrez,

Gomez Moreno AZ

Publication year - 2019

Publication title -

annals of antivirals and antiretrovirals

Language(s) - English

Resource type - Journals

ISSN - 2692-4625

DOI - 10.17352/aaa.000006

Subject(s) - autoimmune hepatitis , hepatitis c virus , medicine , immunology , pathogenesis , virology , hepatitis c , virus , hepatitis

The hepatitis C virus (HCV) infection has been associated with autoimmune diseases, probably due to the interaction between HCV E2 envelope protein and CD-81 receptor of B lymphocyte and thus, can infl uence the pathogenesis of autoimmune liver diseases [1,2]. Therefore, it seems reasonable to consider the benefi cial effect of direct-acting antivirals (DAAs) for HCV in patients with chronic HCV infection and autoimmune hepatitis (HAI), although evidence is scarce.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research